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The benzimidazole moiety is found in various biologically
active compounds having antiviral (Gabril et al., 2001), antiulcer
(Kim et al., 1996), antihypertensive (Roth et al., 1997), anti-
cancer (Moukhoopadhyay et al., 2002), and antihistaminic
properties (Junsens et al., 1985). In addition, benzimidazole
derivatives have been used as topisomerase inhibitors, selective
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lsevierproliferation inhibitors, a treatment for interstitial cystitis, as
factor Xa inhibitors (Zarrinmayeh et al., 1999; Kohara et al.,
1996; Lopez et al., 1990; Fonseca et al., 2001; Zhao et al.,
2000). They also display a great afﬁnity towards a variety of
enzymes and protein receptors (Pason et al., 1999). The most
common synthesis of benzimidazoles involves the reaction be-
tween o-phenylenediamine and a carboxylic acid (or their syn-
thetic equivalents) or aromatic aldehydes (Wang et al., 2006;
Lin et al., 2006; Preston and ‘‘ Chemistry of Heterocyclic Com-
pounds, 1981; Chi and Sun, 2000; Dudd et al., 2003; Curini
et al., 2004; Zheng et al., 2007) under harsh dehydrating con-
ditions. Benzimidazoles have also been prepared on solid
phase to provide a combinatorial approach (Mazurov, 2000).
Recently, R. Kumar et al. Kumar and Joshi (2007) have
reported a one-step synthesis of 2-aryl-1H-benzimidazoles from
the reaction of o-phenylenediamine with various aldehydes in
dichloromethane in the presence of CAN under reﬂux. Also,
o-nitroaniline has evolved to include the synthesis of benzimi-
dazoles via one step reduction and cyclisation (Kim et al.,
2004; Wu et al., 2000). In all of these approaches, the sole
isolable products were 2-aryl-1H-benzimidazoles. Recently,
64 K.U. Sadek et al.(Varala et al., 2007) a selective synthesis of 2-aryl-1-aryl-
methyl-1H-benzimidazoles from the reaction of o-phenylenedi-
amine with aromatic aldehydes catalyzed by L-proline in which
two molecules of aldehyde reacted with one molecule of o-
phenylenediamine has been reported. Ceric ammonium nitrate
(CAN) has emerged as a versatile reagent for a variety of syn-
thetic transformations which have been well documented (Nair
and Deepthi, 2007; Nair et al., 2004). In continuation to our
interest in the synthesis of azoles and azines (Fawzia et al.,
2008; Mekheimer et al., 2008a; Mekheimer et al., 2008b) via
simple, efﬁcient and environmentally friendly techniques we
investigated the reaction of o-phenylenediamine with several
aromatic aldehydes catalyzed by CAN in different solvents
(CH3OH, CH3CN, C6H5CH3) at room temperature, both the
expected products were obtained which revealed the depen-
dence of such condensation on the nature of the solvent and
enabled achieving a direct simple route to benzimidazole
derivatives.
2. Results and discussion
Thus, when o-phenylenediamine 1 was treated with 4-
methoxybenzaldehyde 2a in MeOH in the presence of CAN
(10 mol%) at room temperature a compound of molecular for-
mula C22H20N2O2 (MS = 344 m/e) was obtained in 90%
yield. 13C NMR of the reaction product revealed a methylene
carbon. at d= 46.86 in addition to two methoxy carbons atScheme
Schemed= 54.97 and 55.27 as well as aromatic carbons. 1H NMR
shows a band at d= 5.49 ppm integrated for two protons in
addition to two methoxy and 12 aromatic protons. This ex-
cludes structure 3a since it will reveal two azomethine protons
at d= 8.16 ppm. Consequently, the 2-aryl-1-arylmethyl-1H-
benzimidazole derivative 5a was established for the reaction
product. Similarly, 3,4-dimethoxybenzaldehyde 2b reacts with
1 under the same reaction conditions to afford the correspond-
ing 2-aryl-1-arylmethyl-1H-benzimidazole derivative 5b
(Scheme 1).
The formation of 5a and b was assumed to proceed via the
formation of the dihydro-2-arylbenzimidazole intermediate 8
which condenses with another molecule of the aldehyde under
the effect of the catalyst to afford the 1,4-diazbicyclo (Kim
et al., 1996; Gabril et al., 2001; Gabril et al., 2001) hexane
intermediate 4, which undergoes a thermally allowed 1,3-
hydrogen shift to yield the ﬁnal isolable product 5 (Scheme 2).
In contrast, the reaction of 3-nitrobenzaldehyde 2c with 1
afforded a mixture of 2-(3-nitrophenyl)-benzimidazole 6c and
the 1-arylmethyl derivative 5c in 2:1 ratio. The structure pro-
posed for the reaction products was established based on ana-
lytical and spectral data (see Section 4). The reaction of 1 with
4-chlorobenzaldehyde 2d afforded mainly the corresponding 2-
(4-chlorophenyl)-benzimidazole derivative 6d. The structure of
6d was established based on 1H NMR which revealed besides
the aromatic protons an (NH) band at d= 8.2 ppm. The for-
mation of 6d was proposed to be formed via condensation of1
2
Scheme 3
Table 1 Reaction of aromatic aldehydes with o-
phenylenediamine.
Product Ar Yield (%) m.p. (C) Published
data m.p. (C)
5a 4-MeOC6H4 90 130–131 129–130
5b 3,4-MeOC6H3 89 170–172 –
5c 3-NO2C6H4 15 162–164 –
6c 3-NO2C6H4 55 206–207 207–208
6d 4-ClC6H4 70 293–294 292–293
7 4-O2NC6H4 82 323–325 327
Cerium (IV) ammonium nitrate-mediated reactions: Simple route to benzimidazole derivatives 65one molecule of 2d followed by oxidation of the formed adduct
by the effect of (CAN). The oxidizing effects of (CAN) are well
known and have been established. (Varala et al., 2007) Inter-
estingly, the reaction of benzaldehyde 2e with 1 afforded a
product of molecular formula C13H9N3O2 (Ms = 239 m/e).
The 1H NMR spectrum of this product revealed a singlet at
d= 11.62 integrated for one (NH) proton besides aromatic
protons. Moreover, its 13C NMR reveals absorption bands
for aromatic carbons and 2-benzimadazoyl carbons. Accord-
ingly, structure 7 was established for the reaction product. It
is assumed to be formed via the formation of the correspond-
ing condensation product 6e followed by nitration of the phe-
nyl group at position 2 of the benzimidazole by the action of
(CAN). If nitration of benzaldehyde is prior to the condensa-
tion step it will afford 6c. The nitration process was illustrated
in Scheme 3 in which (CAN) acts as a carrier of nitronium
species and is similar to that observed with metal nitrates
(Goonbes and Russel, 1971) (Table 1).
In order to investigate the quantity effect of CAN on the
reaction yield we studied the efﬁciency of the catalyst ratio
(1, 2, 5, 10, 15 moL%) and we revealed that 10 moL% of
the catalyst was the optimum ratio to carry out the forward
reaction. For less than 10% the yield decreases to 65–70%
while an increase in the quantity of CAN has no signiﬁcant ef-
fect on the overall yield. In addition, methanol was the best
solvent among others (CH3CN, C6H5CH3).
3. Conclusion
The results obtained in our investigation clearly revealed that
the reaction of o-phenylenediamine with aromatic aldehydes
proceeds mainly via two different routes. The ﬁrst is a 1:1 con-
densation followed by oxidation to afford the 2-aryl-substi-
tuted benzimidazoles. Second is a 1:2 condensation to afford
2-aryl-1-arylmethyl-1H-benzimidazole. Both the expected
products were obtained whose ratios depended on the nature
of the solvent. It was previously reported that in methanol asa solvent both 5 and 6 were obtained with 5 as a predominant
one (Salehi et al., 2006).4. Experimental section
Melting points were determined on a Gallenkamp apparatus
and are uncorrected. The reactions were monitored by TLC
(thin layer chromatography) and visualized with UV light.
IR spectra (KBr) were recorded on Perkin–Elmer FTIR model
2000 spectrometer and the NMR spectra were measured on
Bruker-DPX-400 (400 MHz) spectrometer using TMS as an
internal standard. Mass spectra were carried out on a VG-
Autospac-Q high performance tri-sector GC/MS/MS Spec-
trometer. Microanalyses were performed by the Microanalyti-
cal Data Unit at Kuwait University.
4.1. General procedure of the reaction 1 and 2a–d
A mixture of o-phenylenediamine 1 and aromatic aldehydes
2a–d in MeOH (10 mL) was treated with Ceric ammonium ni-
trate (CAN) (10 mol%). The reaction mixture was stirred at
room temperature overnight and then treated with brine solu-
tion. The solid formed was collected by ﬁltration and crystal-
lized from ethanol. In case of 2c a fractional crystallized
from EtOH and EtOH/H2O mixture afforded 5c and 6c.
4.2. 2-(4-Methoxyphenyl)-1-(4-methoxyphenyl)methyl-
1H-benzimidazole 5a
Yield 90%; m.p. 130–131 C (lit Salehi et al., 2006 m.p 129–
130 C); IR (KBr, cm1): tmax = 3060, 3049 (arom. CH),
2986 (aliph. CH), 1609 (C‚C); 1H NMR d, ppm = 7.70–
6.84 (m, 12H, Ar-H), 5.49 (s, 2H, CH2), 3.83 (s, 3H, OCH3),
3.69 (s, 3H, OCH3);
13C NMR d, ppm = 160.31, 158.45,
153.11, 142.64, 138.72 135.80, 130.47, 128.78, 127.37, 122.31,
121.99, 118.94, 114.21, 114.11, 110.97, 55.27, 54.97, 46.86;
MS: m/z (%) 344.15 (34%); Anal. Calcd for C22H20N2O2: C,
76.72; H, 5.85; N, 8.13. Found: C, 76.66; H, 5.80; N, 8.11.
4.3. 2-(3.4-Dimethoxyphenyl)-1-(3,4-dimethoxyphenyl)methyl-
1H-benzimidazole 5b
Yield 89%; m.p. 170–172 C; IR (KBr, cm1): tmax = 3050
(arom. CH), 2999, 2963, 2838 (aliph. CH), 1611 (C‚C); 1H
NMR d, ppm = 7.71–6.43 (m, 10H, Ar-H), 5.50 (s, 2H,
CH2), 3.82, 3.71, 3.68, 3.64 (4 s, 4 OCH3);
13C NMR d,
ppm = 153.17, 149.98, 148.73, 148.58, 147.96, 142.55,
135.99, 129.31, 122.38, 122.35, 122.02, 121.55, 118.93, 117.91,
112.27, 111.74, 111.58, 110.92, 110.03, 55.52, 55.35, 55.31,
55.25, 47.19; MS: m/z (%) 404.17 (77%); Anal. Calcd for
66 K.U. Sadek et al.C24H24N2O4: C, 71.27; H, 5.98; N, 6.93. Found: C, 71.32; H,
5.88; N, 6.92.
4.4. 2-(3-Nitrophenyl)-1-(3-nitrophenyl)-
methyl-1H-benzimidazole 5c
Yield 15%; m.p. 162–164 C; IR (KBr, cm1): tmax = 3054
(arom. CH), 2960 (aliph. CH), 1619 (C‚C); 1H NMR d,
ppm = 8.30–7.20 (m, 12H, Ar-H), 5.80 (s, 2H, CH2); MS:
m/z (%) 374.1 (100%); Anal. Calcd for C20H14N4O4: C,
64.17; H, 3.77; N, 14.97. Found: C, 64.15; H, 3.72; N, 14.86.
4.5. 2-(3-Nitrophenyl)-1H-benzimidazole (6c) and
2-(4-chlorophenyl)-1H-benzimidazole (6d)
The compounds were obtained in 55% and 70% yields and
were found identical with authentic specimens Nagawade
and Shinde, 2006 (m.ps., IR, NMR).
4.6. 2-(4-Nitrophenyl)-1H-benzimidazole 7
Yield 82%; m.p. 323–325 C (lit (Deluca and Kerwin, 1997)
m.p 327 C); IR (KBr, cm1): tmax = 3338 (NH), 3100 (arom.
CH), 2830 (aliph. CH), 1655 (C‚C); 1H NMR d,
ppm = 11.65 (S, 1H, NH), 7.91–7.74 (m, 8H, Ar-H); 13C
NMR d, ppm = 115.2;123.11; 124.42;127.33;135.12;141.70;
147.82;152.22. MS: m/z (%) 239.07 (100%); Anal. Calcd for
C13H9N3O2: C, 65.27; H, 3.79; N, 17.56. Found: C, 65.33;
H, 3.69; N, 17.55.Acknowledgements
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